Africa In The News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa In The News.

Press releases published on October 23, 2026

Oct. 23, 2026

Colaboração Entre Fortrea e Omico Impulsiona Desenvolvimento de Medicamentos Oncológicos Guiados por Biomarcadores

Indeterminate GlobeNewswire

Oct. 23, 2026

ความร่วมมือระหว่าง Fortrea และ Omico…

Indeterminate GlobeNewswire

Oct. 23, 2026

Fortrea 与 Omico 携手，推进生物标志物导向的肿瘤药物开发

Indeterminate GlobeNewswire

Oct. 23, 2026

Fortrea 與 Omico 攜手合作，推動生物標記主導的腫瘤藥物開發

Indeterminate GlobeNewswire

Oct. 23, 2026

Cardtonic Goes Global with USD Settlement, Unlocking Dollar Wallets for Users Worldwide

Indeterminate GlobeNewswire

Oct. 23, 2026

Kyverna Therapeutics Highlights Promising Updated Clinical Data with Miv-cel in Progressive Multiple Sclerosis at MS Toronto 2026

Indeterminate GlobeNewswire

Oct. 23, 2026

Hercules Metals Announces Upsize of "Bought Deal" Private Placement of Common Shares to $45 Million

Indeterminate GlobeNewswire

Oct. 23, 2026

GFG Closes Upsized Financing of $8.1 Million

Indeterminate GlobeNewswire

Oct. 23, 2026

MacroGenics Announces Positive Interim Phase 1 Results for MGC026 and Highlights Plans to Initiate Front-Line Combination Study in SCCHN

Indeterminate GlobeNewswire

Oct. 23, 2026

Onconetix Provides Additional Strategic Bridge Financing to Realbotix LLC in Continued Support of Pending Acquisition

Indeterminate GlobeNewswire

Oct. 23, 2026

Revolution Medicines Presents Overall Survival Data for RASONQUE™ (daraxonrasib) Across Subgroups in Previously Treated Metastatic Pancreatic Cancer at ESMO 2026

Indeterminate GlobeNewswire

Oct. 23, 2026

Aardvark Therapeutics Reports Exploratory Data from the Terminated HERO and Open-Label Extension Trials

Indeterminate GlobeNewswire

Oct. 23, 2026

Tango Presents Promising Results from Phase 1/2 Study of Vopimetostat and Daraxonrasib in Pancreatic Cancer and Provides Updates to Development Strategy

Indeterminate GlobeNewswire

Oct. 23, 2026

Zymeworks Enters into an Exclusive Global License and Collaboration Agreement with Roche for ZW209, a Trispecific T cell Engager Targeting DLL3

Indeterminate GlobeNewswire

Oct. 23, 2026

Enterome Phase 1/2 data show OncoMimics™ EO4010-induced CD8 T-cell expansion was associated with longer survival in patients with colorectal cancer

Indeterminate GlobeNewswire